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Bionic Cartilage Acellular Matrix Microspheres as scaffold for 
engineering cartilage
Jun Liu,a Xiuyu Wang,b Gonggong Lu,a James Z. Tang,c Yonghui Wang,b Boqing Zhang,a Yong Sun,a 
Hai Lin,a Qiguang Wang,*a Jie Liang,a Yujiang Fan*ab and Xingdong Zhanga
Extracellular Matrix (ECM) scaffolds made from decellularized natural cartilage has been successfully used in cartilage 
lesion repair, but allogeneic cartilage donors are always in shortage and xenogeneic cartilage tissues may have the risk of 
unknown disease transfer. In this study, we constructed artificial bionic cartilage microspheres by encapsulating MSCs in 
collagen microspheres and cultured in chondrogenic inducing medium. Then, acellular matrix microsphere (BCAMM) 
scaffolds were fabricated from cultured microspheres at three different developmental stages. A novel technique was 
introduced to fabricate BCAMM scaffolds, which achieved in a short time to produce and utilize the scaffolds. Due to the 
differences in surface morphologies and biological compositions, three BCAMM scaffolds demonstrated different 
chondrogenic effects. The 10-day BCAMM (10-BCAMM) scaffold showed the best overall results, successfully inducing the 
MSC chondrogenesis without any additional fetal bovine serum or induction components (TGF- or dexamethasone). In 
comparison, the 5-day BCAMM (5-BCAMM) scaffold showed the potential osteogenic effects. The advantage of micron-
size BCAMM are outlined, specifically in the easier decellularization process without grinding, homogeneous cell seeding 
and infiltration, chondrogenic induction and better fitting into the irregular lesion shape.
1. Introduction
Articular cartilage has a very limited self-repair capability due 
to its low-cell and avascular nature1,2. Autologous stem cells 
were chosen to be the seeding cells due to their potential to 
differentiate into chondrocytes and more accessible than 
articular chodrocytes3. Current strategies to promote cartilage 
healing and regeneration have been directed towards 
improving the chondrogenesis of stem cells by different 
biomaterials. However, the outcome is not always guaranteed, 
due to the lack of stem cell’s chondrogenic differentiation and 
the unstable phenotype of induced chondrocyte-like cells4-6. 
Tissue engineering scaffolds are ideally providing cells with 
biomimetic microenvironments which improve the cell 
proliferation and functional restoration, or facilitate the 
differentiation of stem cells.7 Synthetic scaffolds can be 
designed to mimic some features of natural Extracellular 
Matrix (ECM) structure8-10. However, these scaffolds couldn’t 
completely reproduce the complicated ECM 
microenvironments. 
ECM scaffolds are another type of scaffolds made from 
decellularized natural tissues or in vitro cultured tissues. They 
normally offer excellent biological properties to regulate the 
differentiation of stem cells and have been widely used in 
clinical treatments, which are associated with skin, cornea, 
cartilage, tendon and heart valves.11-16 Allogeneic cartilage 
donors are always in shortage and xenogeneic cartilage tissues 
may have the risk of unknown disease transfer.17-19 Natural 
mature cartilage are most widely used for the preparation of 
ECM scaffolds due to its relatively better availability. However, 
Visser et al. observed calcified tissue formation in the 
cartilage-like tissue when using gelatin methacrylamide 
hydrogels combined with natural cartilage derived matrix, 
even with additional chondrogenic factors14, suggesting that it 
is difficult to maintain a stable the chondrogenic phenotype of 
MSC-derived chondrocytes. In the study of Almeida et al., 
scaffolds made from decellularized engineered cartilage 
loaded with TGF- supported comparable levels of GAG 
synthesis to native ECM scaffolds.20 
During the natural cartilage development, mesenchymal 
stem cells (MSCs) undergo migration, proliferation and 
condensation.2,21,22 At different stages, MSCs secrete different 
proteins, cytokines and growth factors in the ECM, which may 
result in their different effects in regulating the MSCs 
differentiation. In our previous study, we found that the 
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chondrogenesis of MSCs in three-dimensional (3D) collagen 
hydrogel microsphere (CHM) culture system could partly 
mimic the natural process of cartilage formation, especially for 
the cell migration, condensation, abundant cartilage specific 
matrix secretion and low hypertrophic gene expression.23 The 
cartilage-like tissue formed from above culture were named 
bionic cartilage microspheres (BCM), which contained the 
homogeneous cartilage specific matrix, including 
glycosaminoglycans (GAGs) and type II collagen. 
In this study, we developed a novel method to obtain 
acellular matrix from BCM cultured for different time to mimic 
the MSCs chondrogenic differentiation at different stages 
(Scheme 1). We demonstrated the advantages of bionic 
cartilage acellular matrix microspheres (BCAMM) during its 
fabrication and ultlization: (1) 500 mg BCM (corresponding 
volume was ~ 1000 mm3) could be fabricated from 3.6 ×106 
cryopreserved MSCs (passage 2) within 15 days; (2) Micron 
size of the BCM would allow a new decellularization 
methodology to obtain BCAMM without grinding to preserve 
the natural ECM structure; (3) Large surface area and micron-
size scale of the BCAMM would further enhance the cell 
adhesion, cell infiltration, mass transfer and better integration 
into the irregular lesion area; (4) Extremely low number of 
MSCs (only 1 ~ 4 ×104 cells/mg) were required to seed on the 
scaffold, which reduced the requirement of patient’s MSCs in 
clinical and the in vitro cell expansion duration and cost. The 
obtained BCAMM expressed different chondrogenic effects 
due to the differences in surface morphologies and biological 
compositions. The decellularization effectiveness, key ECM 
reservation and the chondrogenic effects of BCAMM at 
different developmental stages were investigated.
2. Materials and Methods
Materials
Collagen type I was extracted from a new born calf skin and 
dissolved in a 0.5M acetic acid solution. Alpha-modified Eagle’s 
Medium (-MEM) and Dulbecco’s Modified Eagle Medium 
(DMEM) were purchased from Hyclone. 4’-6-diamidino-2-
phenylindole (DAPI) was obtained from Beyotime 
Biotechnology, China. DNAse I, L-ascorbic acid 2-phosphate, L-
proline, Dexamethasone, ITS+Premix was purchased from 
Sigma-Aldrich, USA.  Nonessential amino acid (NEAA) and Fetal 
Bovine Serum (FBS) were obtained from Gibco, USA. TGF-1 
was obtained from PeproTech, USA. Fluorescein diacetate 
(FDA), propidium iodide (PI), Triton X-100 and alizarin red were 
obtained from Solarbio, China. TRITC-labeled phalloidin was 
purchased from YEASEN Bio, China. Anti-TGF-1 antibody 
(ab190503) and anti-BMP2 (ab6285) were purchased from 
Abcam, USA. Anti-IGF1 (nbp2-34361), anti-VEGF (nbp2-45235), 
anti-PEDF (mab1177), anti-COL1 (nb600-450), anti-COL2 
(nbp2-33343) antibodies were obtained from NOVUS, USA. 
Alexa Fluor488-affiniPure Goat Anti-Mouse IgG was purchased 
from Jackson ImmunoResearch, USA. Goat serum and 
polyperoxidase-anti mouse IgG were obtained from ZSGB-BIO, 
China. Blyscan GAG assay kit was obtained from Biocolor, UK. 
All other chemicals were purchased from Chengdu Kelong 
unless otherwise specified.
MSCs isolation
In brief, neonatal New Zealand white rabbit (Breeding Farm for 
Sichuan Provincial Experimental Animal Special Committee) 
was sacrificed. Under sterile condition, long bones were 
collected and the bone marrow was flushed out with -MEM 
containing 20% FBS and antibiotics (penicillin 100 U/mL, 
streptomycin 100 g/mL) by a syringe. Bone fragments were 
removed by cell strainer (70 m, BD Falcon, USA). After 
centrifugation, filtered bone marrow cells were resuspended 
in the medium and cultured in the 10-cm cell culture dishes at 
37°C with a humidified atmosphere of 5% CO2. Non-adherent 
cells were removed by replacing fresh medium after a 24 h 
Scheme 1. Schematic representation of BCAMM fabrication process. Scale bars represented 1 mm
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culture. The MSCs were passaged until a confluence of 90%. 
The MSCs of forth passage were used to fabricate CHM.
Fabrication of bionic cartilage microsphere (BCM)
Collagen solution was neutralised with 1M NaOH. MSCs were 
counted and resuspended in the culture medium. Collagen 
solution was adjusted to the final concentration of 6 mg/mL 
with the cell solution. The final cell density was 5.0×106 
cells/mL. The collagen-cell mixture was injected into the 
stirring PDMS and the speed was set at 500 rpm. The system 
was moved to a 37C water bath after 10 min stirring and kept 
stirring for another 20 min. After gelation, CHM were collected 
and washed with the culture medium 3 times. CHM were then 
cultured in a MSCs medium for 6 hours and then replaced the 
medium with a chondrogenic medium (DMEM medium, 1% 
penicillin-streptomycin, 90 mg/mL L-ascorbic acid 2-phosphate, 
0.35 mM L-proline, 100 nM dexamethasone, 10 ng/mL TGF-1, 
1% insulin-transferrin-selenite-linoleic acid (ITS+) and 1% 
NEAA) to induce cartilage-like tissue regeneration. The culture 
was conducted in vitro for a total of 15 days, and the BCMs at 
day 5, 10, and 15 were collected respectively.
Fabrication of bionic cartilage acellular matrix microsphere 
(BCAMM):
BCMs harvested at different time points (5 days (5-BCM), 10 
days (10-BCM), and 15 days (15-BCM)) were decellularized to 
fabricate the corresponding BCAMMs. Firstly, BCMs were 
washed with a hypotonic solution and a hypertonic solution 3 
times. The BCMs were frozen in liquid nitrogen and thawed in 
a 37C water bath 6 times. Then BCMs were immersed in the 
0.5% Triton X-100 solution containing 20mM ammonium 
hydroxide for 20 min and washed with water 3 times. 20KU 
DNAse I was dissolved in 1 mL Tris-HCl buffer (25 mM, Ph=7.5) 
containing 50% glycerol, 5 mM CaCl2 and 5 mM MgCl2 as stock 
solution. Before using, the DNAse I stock solution were diluted 
100-fold with reaction solution (Ph=7.5) which contains 10 mM 
Tris-HCl and 2 mM MgCl2 to the prepare the working solution. 
The 200U/mL DNAse I working solution was used to remove 
the DNA in the BCM at 37C for 3 hours and the solution was 
replaced twice every 3 hours. Finally, BCMs were washed with 
Triton X-100 solution and water 3 times, followed by 
crosslinked with 0.1% glutaraldehyde for 20 min. BCAMMs 
were frozen by liquid nitrogen and stored in the refrigerator at 
-20C before use. 
Removal of DNA
BCAMMs fabricated from different BCMs (5-BCAMM, 10-
BCAMM and 15-BCAMM) were fixed with 4% 
paraformaldehyde and then embedded in paraffin. The 6 m 
sections were prepared and stained by DAPI to confirm the 
removal of cells. 
Surface morphology
Environmental scanning electron microscope (ESEM, FEI 
Quanta 650) was used to character surface morphologies of 
scaffolds. 
Cytokines in the scaffold
Immunohistochemical staining was used to detect remnant 
cytokines in scaffolds. After blocked with goat serum for 2 
hours, sections were incubated with primary antibodies of 
TGF-1, BMP-2, IGF-1, PEDF and VEGF for 10 hours. Then the 
sections were washed with TBS 3 times, followed by incubating 
with second antibody in the cassette. The sections stained by 
the same antibody were imaged by confocal laser scanning 
microscopy (CLSM, TCS SP 5, Leica) with the same parameters.
Cell seeding and culture
MSCs of third passage were seeded on the BCAMM at the 
density of 4×104 cells/mg and cultured in the MSCs culture 
medium (-MEM containing 10% fetal bovine serum) for 
adhesion. To eliminate the effect of cytokines in the serum and 
the differentiation effect of dexamethasone (which was 
confirmed in the pre-experiment, in the Figure S1), we used 
the culture medium without TGF-, dexamethasone and 
serum. After a 24 hours cells adhesion, samples were cultured 
in the DMEM medium containing 1% penicillin-streptomycin, 
90 g/mL L-ascorbic acid 2-phosphate, 0.35 mM L-proline, 1% 
ITS+Premix and 1% nonessential amino acid for 28 days. 
Cell viability and cell morphology
Cell viability was assessed with FDA/PI double staining after 1 
and 7 days culture. All samples were washed with PBS and 
incubated in the FDA-PI (1 g/mL) dyeing solution for 5 min. 
Then samples were washed with PBS again before observed 
with CLSM. The CLSM pictures were analysed by ImageJ 
software (1.51j8, National Institutes of Health) to calculate 
cells’ circularity. For cell morphology, samples were stained 
with TRITC-labeled phalloidin for 20 min and DAPI for 30 
seconds to show the cytoskeleton, followed by washed with 
PBS before observed with CLSM. 
Gross morphology and weight change of samples
Samples at day 7, 14 and 28 were imaged by digital camera 
and the size was measured. To observe degradation and neo-
tissue formation, the wet weight and dry weight of samples 
were measured by an electronic analytical balance (Mettler 
Toledo XP205). 
Immunohistochemical staining
Immunohistochemical staining was used to confirm the 
secretion of collagen type I and II in the matrix. After in vitro 
culture, samples were washed with PBS and then fixed with 4% 
paraformaldehyde at 4°C for 24 h, followed by paraffin section 
in 6 m. For immunohistochemical staining, primary 
antibodies of COL1 and COL2 were used. Sections were 
blocked with a goat serum for 2 hours and then incubated with 
primary antibodies at 4°C for 10 hours. After being washed 
with TBS 3 times, sections were immersed in the 0.3% H2O2 for 
10 min, followed by polymer helper for 20 min and second 
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antibody for 20 min. Finally, Diaminobenzidine (DAB) was used 
to visualise the peroxidise labelled antibody for 5 min and 
observed under microscope. 
Alizarin Red staining of mineral deposition
Alizarin Red was used to detect the mineral deposition in the 
BCAMMs after in vitro culture. Sections were immersed in the 
95% ethanol before 5 min staining of Alizarin Red S (pH=4.2). 
After washing with water to remove residual staining liquid 
and dehydration, slides were observed under microscope.
GAG staining and quantitation
To characterise the remnant GAGs in the BCM before or after 
decellularization and the GAGs secretion by MSCs in the 
BCAMM, the lyophilised samples were digested in the papain 
solution (0.1mg/mL) at 60 ℃  for 12 hours before measured 
with the BlyscanTM GAG assay Kit. Briefly, a 40 l supernatant 
was mixed with BlyscanTM dye reagent. After centrifugation, 
the sGAG-dye complex was dissolved in the dissociation 
reagent and followed by the measurement of absorbance at 
650 nm in the reader. Histological staining was used to confirm 
the secretion and distribution of cartilage specific matrix in 
samples. For histological staining, Toluidine Blue (TB) was used 
to detect GAGs by the positive staining with a purple colour. 
DNA content
DNA contents in the BCM before or after decellularization 
were determined to confirm the removal of cell nucleus. The 
proliferation of MSCs on the BCAMM was also measured by 
the same method. Briefly, a 10 L digestion liquid was added 
into 2mL of a Hoechst 33258 solution and measured by 
fluorometry. 
Micro-CT
To detect the calcific tissue, samples underwent micro-CT 
scans (VivaCT80, SCANCO Medical). The parameters were 70 
kV tube voltage, 114 mA tube current and 50 m resolution. 
Images were reconstructed by Mimics 17.0 software 
(Materialize). The degree of calcification was presented as the 
ratio of calcific tissue volume to total tissue volume.
Statistical Analysis
All results were presented as mean ± standard error of the 
mean (SEM). The one-way ANOVA was carried out to test the 
significance of the differences among the study groups. 
Statistical differences were shown with three significance 
levels; *P<0.05, **P <0.01 and ***P < 0.001.
3. Results 
3.1. Fabrication of BCAMM scaffolds
3.1.1. Effective decellularization of BCM
Figure 1. Decellularization effect. A) DAPI and TB staining of 5-BCM, 10-BCM, 15-BCM and 5-BCAMM, 10-BCAMM, 15-BCAMM. 
Scale bars represented 100 m. B) DNA content of BCMs (Left y-axis) and BCAMMs (Right y-axis). C) GAG content of BCMs 
before and after decellularization. Data are expressed as the mean ± SEM (n=3~4). ***presents P<0.001.
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The effects of the decellularization process on the BCM were 
shown in Figure 1. After DNAse I treatment, DNA in the BCM 
was degraded by enzymes. The two rows of Figure 1A show 
DAPI staining of DNA before (BCM) or after (BCAMM) 
decellularization. The DNA content of BCM and BCAMM was 
quantified and shown in the Figure 1B. After decellularization, 
only about 0.11% ~ 0.19% DNA was left in the BCAMM, which 
indicating that DNA was effectively washed away by this 
decellularization method, in agreement with the findings of 
DNA staining in Figure 1A. The second row of Figure 1A 
showed the TB staining of BCM or BCAMM. Before 
decellularization, GAGs were intensively stained in the BCM. 
After treatment with decellularization regents, most of GAGs 
were washed off, leaving an almost invisible ECM network. The 
GAG content analysis before (BCM) or after (BCAMM) 
decellularization in Figure 1C supports this with 6.4%, 19.7% 
and 18.4% of GAGs remaining in the 5-BCAMM, 10-BCAMM 
and 15-BCAMM after the decellularization. 
3.1.2. Distinct surface morphology of different BCAMMs
Surface morphologies of BCMs and BCAMMs in Figure 2 
revealed some interesting features which were in favour of cell 
attachment, proliferation, and possibly differentiation. All BCM 
surfaces showed distinct cellular-like structures with entities 
less than 10 m. In comparison, All BCAMM surfaces lost the 
cellular-like structures. The 5-BCAMM and 10-BCAMM 
demonstrated a distinct featured morphology with a rougher 
surface compared to that of the 15 BCAMM, which had shown 
the smoothest surface among the three.
3.1.3. Key cytokines remained in BCAMMs
The immunohistochemical staining of TGF-β1, BMP-2, IGF-1, 
PEDF and VEGF were revealed in Figure 3. Among three 
BCAMMS, the BMP-2, IGF-1 and VEGF staining intensities 
increased in BCAMMs. In contrast, PEDF staining was observed 
in 5-BCAMM and 10-BCAMM, but the intensity was decreased 
in the 15-BCAMM. Moreover, the TGF-β1 staining wasn’t 
visually different in 5-BCAMM, 10-BCAMM and 15-BCAMM 
samples.
3.2. MSCs culture on BCAMMs
3.2.1. BCAMMs impact on cell morphology and proliferation
Different effects of BCAMMs on the seeding cells’ morphology 
and proliferation were shown in Figure 4. It was clear that 
most of cells were viable (green) after 7 days’ culture without 
visible death of cells (Figure 4A). In comparison, there were 
visually more cells and cell interconnection on the 5-BCAMM 
and 10-BCAMM than the 15-BCAMM at day 1. As MSCs were 
initially seeded at the same cell density in all samples, it also 
reflected to the cell seeding efficiency of the 5-BCAMM and 
10-BCAMM in consideration of the day-1 FDA-PI staining. The 
cell morphology was studied by exploitation of the F-actin 
staining (Figure 4B) and validated with circularities of cells 
using ImageJ software (Figure 4C). The combination of 
phalloidin & DAPI staining showed the cell skeleton (red) and 
nucleus (blue). The day 1 results indicated that most MSCs on 
the 5-BCAMM had fibroblast-like morphology and most MSCs 
on the 15-BCAMM had spherical morphology; while those on 
the 10-BCAMM did not have such preferences. To validate 
these observations, the roundness of MSCs was further 
analysed by calculating the circularities of cells. The average 
Figure 2.  ESEM image of surface morphologies of 5-BCM, 10-BCM, 15-BCM and 
5-BCAMM, 10-BCAMM, 15-BCAMM. Scale bars represented 10 m.
Figure 3.  Immunohistochemical staining of TGF-β1, BMP-2, IGF-1, PEDF and VEGF in the 
BCAMMs. Scale bars represented 50 m.
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circularities of MSCs on the 5-BCAMM, 10-BCAMM and 15-
BCAMM at day 1 were 0.366, 0.490 and 0.582, respectively. 
The higher value means the more roundness of cells, indicating 
that cells were more spherical in the sample. On day 7, the cell 
morphology wasn’t visually changed much, as some fibroblast-
like cells were still on the 5-BCAMM. Compare to day 1, there 
were visually much more cells at day 7 on all samples, 
suggesting that all three BCAMMs had a good 
cytocompatibility and could support cells’ proliferation 
without additional serum. The dark area without green 
fluorescence was observed in the 5-BCAMM at day 7, which 
was possibly caused by the loss of support to the cell adhesion 
after the scaffold degradation. After the initial increase in cell 
number, the DNA content decreased gradually from day 7 to 
day 28 (Figure 4D), which reflected the decrease of the cell 
number. According to the 6.5~9.3 pg DNA per MSCs reported 
by literature,24-26 the initial theoretical maximum DNA content 
was 0.74 g/mg and that confirmed the MSCs proliferation 
during the period of day 1 to day 7. Those phenomena might 
be caused by the chondrogenic differentiation of MSCs, as the 
DNA content had been previously reported to decline during 
chondrogenesis. 27-29
3.2.2. Influence of BCAMMs on GAGs synthesis
After seeding cells, the appearance and the solid content of 
BCAMMs changed. On the day 7, the initial micron size 
BCAMMs (showed in the Scheme 1) had cohered to be one 
larger bulk (Figure 5A). All BCAMM showed great integration 
ability. The Figure 5B showed the TB staining of GAG secreted 
by the MSCs in various BCAMM samples at different time 
points. Among three samples, sample 10-BCAMM had a 
visually more positive staining increase with time. 5-BCAMM 
registered positive staining peaks at Day 14 but faded from 
Day 14 to Day 28. Fastest degradation speed of 5-BCAMM 
scaffold resulted in shrinkage and even breakdown of the 
matrix network in comparison to those of the sample 10-
BCAMM that demonstrated a significant different matrix 
network corresponding to the positive staining. Due to the 
slowest degradation speed of scaffold, sample 15-BCAMM had 
slower inner cell growth and secretion of cartilage specific 
matrix. Furthermore, the quantitated GAG content in all three 
samples on day 28 also echoed the histological TB staining 
result (Figure 5C), and the GAGs synthesised in sample 10-
BCAMM had achieved significantly more quantity than the 5-
BCAMM and 15-BCAMM samples. Solid contents of three 
samples on day 0, 7, 14 and 28 were calculated and showed in 
the Figure 5D. The solid content of the 5-BCAMM decreased 
before the day 7 and then increased steadily up to day 28, 
whereas that of the 10-BCAMM’ had no change in the first 7 
days before the steady weight increase with time up to day 28. 
In comparison, the solid content of sample 15-BCAMM 
increased with time but at a lower rate except the first 7 days. 
Among all three samples, 10-BCAMM had achieved the highest 
solid content (33.26%) on day 28, followed by 5-BCAMM 
(29.30%), and 15-BCAMM (27.88%). 
Figure 4. MSCs culture on BCAMM. A) FDA/PI image of MSCs on day 1 and day 7. Scale bars represented 100 m. B) F-actin 
staining image on day 1. Scale bars represented 10 m.  C) Circularity of MSCs on the day 1. D) DNA content of total cells on the 
BCAMM. Data are expressed as the mean ± SEM (n=3). * presents P<0.05, ** presents P<0.01, ***presents P<0.001.
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3.2.3．Collagen deposition
Figure 6 shows the immunohistochemical staining of collagen 
type I and collagen type II, which reflect the accumulation of 
cartilage specific collagen. Throughout the 28 day’s culture, 
sample 5-BCAMM showed the highest collagen type I staining 
among three samples, and its staining intensity increased with 
time in Figure 6A. There was less collagen type I staining in 
sample 10-BCAMM at day 7 and the staining kept at a low level 
at both day 14 and 28 days. In contrast, sample 15-BCAMM 
had minimal collagen type I staining at day 7 and 14, but the 
staining increased a little at day 28. Collagen type II was the 
specific collagen of articular hyaline cartilage. The day 1 
staining (Figure 6B) showed the collagen type II preserved 
from the BCMs. As the 15-BCAMM scaffold was fabricated 
from a more matured BCM, the collagen type II staining was 
more intensive than other two BCAMMs. After 28 days, the 
collagen type II staining intensity was increased in all three 
scaffolds, despite the 5-BCAMM structure collapsed.  
3.2.4. The 5-BCAMM culture leads to Mineral deposition
Figure 5. A) Metallographic microscope pictures of samples. Scale bars represented 1000 m B) TB staining image of 
BCAMMs after culture with MSCs. Scale bars represented 50 m. C) GAG content of BCAMMs after culture with MSCs. D) 
Solid content of BCAMMs after culture with MSCs. Data are expressed as the mean ± SEM (n=3). ** presents P<0.01, 
***presents P<0.001.
Figure 6. Immunohistochemistry of BCAMMs after culture with MSCs. A) Collagen Type I. B) Collagen Type II. Scale bars represented 
50 m.
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Different degrees of mineral deposition could be found in the 
BCAMMs after cultured with MSCs (Figure 7). All samples had 
no mineralization deposition at day 1 as revealed by the 
alizarin red staining (Figure 7A). On day 28, there were lots of 
positive red staining areas in sample 5-BCAMM, indicating the 
mineralization deposition. In comparison, there were less to 
none staining areas to be observed in sample 15-BCAMM and 
10-BCAMM. Micro-CT images (Figure 7B) showed the size of 
the calcific tissue in the whole sample, and the result was 
consistent with the alizarin red staining. Sample 5-BCAMM had 
the largest calcific volume, which occupied about 28.4% of 
total sample volume. In contrast, the calcific volumes of 
sample 10-BCAMM and 15-BCAMM were much smaller and 
the percentages were about 2.8% and 3.1%, respectively. 
Similar results were also observed in another experiment 
under the culture medium containing 1% serum that sample 5-
BCAMM and sample 15-BCAMM had calcific tissue while none 
mineralization was found in the sample 10-BCAMM (Figure S2).
4. Discussion 
Based on our previous study, bionic cartilage microspheres 
could be made in vitro within 15 days and the chondrogenic 
genes expression was stable.23 Combining the collagen 
microspheres culture system and the microsphere 
decellularization technique, we had managed to fabricate 
three ECM scaffolds (5-BCAMM, 10-BCAMM, and 15-BCAMM) 
from allogeneic MSCs, and conducted a comprehensive 
evaluation to their chondrogenic inductivities. To avoid any 
potential chondrogenic effect from cell culture medium and to 
mimic the limited nutrient microenvironment in the natural 
articular cartilage, we used the basic culture medium without 
any FBS that may contain extra nutrients and various unknown 
cytokines. Neither TGF- nor dexamethasone was added in 
order to avoid their induction ability, as observed in our pre-
experiments (in Supplementary Information Figure S1). To our 
knowledge, this is the first study that successfully induced the 
in vitro chondrogenic differentiation of MSCs solely by the 3D 
decellularized scaffold, without any additional serum and 
induction components. 
Seeding cells’ fate would be greatly affected by the 
properties of scaffolds, including the cytotoxicity, chemical 
contents, surface morphology and degradation speed. 8,30-33 In 
our study, it was found that differences in three BCAMMs 
clearly influenced the cell seeding efficiency and the cell 
morphology. FDA-PI images demonstrated that more cells 
were attached on sample 5-BCAMM and 10-BCAMM than 15-
BCAMM scaffolds on day 1, and the Phalloidin & DAPI staining 
showed a high percentage of fibroblast-like cells in the sample 
5-BCAMMs but more circular cells were observed in sample 
15-BCAMMs. The phenomenon was coincided with the study 
of Hallab et al. that polymers showed an increase of the 
cellular adhesion strength associated with the increase of the 
surface roughness.34 According to previous study, collagen 
Type I in the microspheres decreased with the extended 
culture of BCM. Thus the 5-BCM might remain more collagen 
type I due to the shorter culture time, and the more remnant 
collagen type I in 5-BCAMM might also facilitate the adhesion 
of cells. In addition, it is generally believed that fibroblast-like 
cells would proliferate faster than circular cells and apply more 
contraction force to the surrounding scaffold network.33 
However, with the highest percentage of fibroblast-like cells in 
sample 5-BCAMM, its fast degradation (TB staining at day 7) 
resulted in a lower cell number at latter stages (14 and 28 
days). In contrast, more circular cells in sample 15-BCAMMs 
resulted in a lowest seeding efficiency and proliferation rate in 
all three scaffolds, but its degradation was the slowest 
throughout the culture period. Sample 10-BCAMMs had a 
balanced number of both fibroblast-like cells and circular cells, 
which resulted in the highest DNA content at day 28.
It had been widely accepted that a high cell density would in 
favour of chondrogenic differentiation,35-37 but the result of 
sample 5-BCAMMs showed that the fast degradation of 
scaffold before neo-tissue formation caused by too much 
Figure 7. Mineralization deposition in the BCAMMs after culture with MSCs. A) Alizarin Red staining. Scale bars 
represented 100 m. B) Micro-CT image of calcified tissue in samples. Scale bars represented 500 m.
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spread cells was not a good condition. In contrast, the best 
overall results achieved by the 10-BCAMM had perfectly 
proved the tissue engineering theory that the degradation 
speed should match speed of the neo-tissue formation.38-40 
Furthermore, it had been reported that the spheroid 
phenotype of MSCs would help to promote the 
chondrogenesis and the fibroblast-like phenotype would 
contribute to the osteogenesis. In the study of Kang et la., 
spreading MSCs on the graphene oxide-collagen scaffold had a 
higher expression of ALP and OP.41 Another study of Cao et al. 
also showed that the spreading chondrocytes had a lower 
expression of COL2, AGG and SOX9. 42 In coincide with above 
literatures, our results demonstrated that sample 5-BCAMM 
with more fibroblast-like cells had finally turned into a large 
amount of calcified tissue, while sample 10-BCAMM and 15-
BCAMM with more circular cells had resulted in more 
cartilaginous tissue. 
Soluble GAGs in the ECM would be easily washed off during 
the decellularization procedure, as Falguni et al. found that 
only 25% of GAGs were remained after decellularization of 
natural cartilage.31 In our study, we also couldn’t help to 
prevent this common phenomenon. However, our scaffolds 
had managed to preserve many key ECM components after 
decellularization. Various cytokines remained in the different 
BCAMMs might be the vital factor leading to the different 
inducibilities of three BCAMM scaffolds. Many studies had 
reported that BMP-2 was an important cytokine during 
chondrogenesis, with the function to enhance the effects of 
TGF- and promotes maturation of chondrocytes.43-45 As 
another important cytokine, IGF-1 was found to be responsible 
for promoting accumulation of cartilage matrix. 21,43,46,47  There 
were more IGF-1 remained in sample 10-BCAMM and 15-
BCAMM than 5-BCAMM; suggesting the former two scaffolds 
may theoretically hold a higher chondrogenic inducibility than 
sample 5-BCAMM. It explained well that sample 10-BCAMM 
and 15-BCAMM had resulted in more GAG and type II collagen 
production than sample 5-BCAMM. In the study of Rong et al., 
MSCs were seeded on PLGA mesh and fabricated ECM 
scaffolds after 7 or 21 days culture.22 The results showed that 
7-day-ECM sample was richer in the cartilage matrix than 21-
day-ECM, which was consistent with our result that sample 10-
BCAMM was better than sample 15-BCAMM. Together, it 
encouraged the investigations of ECM scaffolds during the 
developmental stage.
Tissue mineralization was a common phenomenon during 
chondrogenesis of MSCs in vitro and cartilage regeneration in 
vivo. Farrell et al. found that MSCs-seeded agarose hydrogels 
without TGF-  were heavily calcified after a long time 
culture.6 A high degree of calcification was found in gelatin 
methacrylamide hydrogels with embedded MSCs and 
cartilage-derived matrix particles after subcutaneous 
implantation.14 VEFG had a great effect on the 
neovascularization during endochondral bone formation and 
PEDF could inhibit angiogenesis and counteract with 
VEGF.43,48,49 Sample 5-BCAMM contained the most PEDF and 
the least VEGF. However, the failure of chondrogenesis and 
fibroblast-like morphology of MSCs led to osteogenesis of 
sample 5-BCAMM with the heaviest calcification, as evidenced 
by the collagen type I and alizarin red staining. There was a 
slight difference between sample 10-BCAMM and 15-BCAMM 
that more calcific tissue was quantified in sample 15-BCAMM 
probably because of the higher VEGF content in the 15-
BCAMM that could enhance the collagen type I secretion and 
decrease the GAG secretion of MSCs during the late 
period.50,51
ECM scaffolds had been used in clinical treatments for decades. 
However, due to the shortage of allogenic tissue and the unknown 
disease risk of xenogeneic tissues, harvesting the sufficient number 
of suitable ECM scaffolds in clinical had been always a challenge. 
Advantage of microsphere culture system had been reported 
previously in our research, as more GAG production and more 
stable phenotype was achieved by the chondrocyte cultured in 
microspheres compare to bulk hydrogel.52,53 In this study, we had 
demonstrated a cost-effective methodology to fabricate ECM 
scaffolds (BCAMM) by combining the collagen microspheres culture 
system and the microsphere decellularization technique. Based on 
our previous study, about 500 mg BCM (= 1000 mm3 volume) could 
be fabricated from 3.6×106 cryopreserved MSCs (P2) within 7~17 
days from time point of recovering cells. To minimise DNA residues 
in the ECM scaffold, tissues were normally cut into pieces and 
grinded into slurry before decellularization, especially for dense 
tissues like cartilage. However, grinding tissues into slurry during 
the decellularization process would partly destroy the tissue 
structure and consequently undermine the ECM 
microenvironments, which was crucially important for MSCs 
differentiation.30,54 Unlike the traditional ECM scaffold, micron-sized 
BCMs could be decellularized to BCAMMs without grinding. 
Compare to the previous decellularization technique for 
chondrocytes microspheres55, our decellularization process 
effectively removed 99.89% DNA without using sodium 
deoxycholate, which was an anionic, bile-acid detergent that might 
disrupt and dissociate many types of protein interactions. 
Consequently, the gentler decellularization process preserved the 
crucial microstructure and various cytokines at different 
developmental stages to influence the chondrogenic differentiation 
of MSCs. Among BCAMM scaffolds prepared at different time 
points, the 10-BCAMM showed the best chondrogenic induction 
ability and a better anti-mineralisation ability. Furthermore, as the 
MSC percentage gradually declined with age in adult,56,57 we tested 
an even lower cell seeding density of 1×104 cells/mg on the 
BCAMMs, by conducting the in vitro culture in the culture medium 
with 1% FBS. After 28 days, a large mass of GAGs was secreted as 
shown in the Figure S2, which had demonstrated the usefulness of 
BCAMMs with very low cell numbers. It would be a welcomed 
advantage to use less MSCs in clinical; in terms of the treatment 
complexity, patient’s welfare and the cost.
5. Conclusion 
BCAMM scaffolds derived from MSCs at different 
differentiation stages had all demonstrated chondrogenic 
effects to MSCs without any additional serum or induction 
components. The best chondrogenic effects were achieved by 
sample 10-BCAMM, which not only had the highest cartilage 
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matrix production, but also inhibited the matrix calcification. 
The study also provided a novel technique to fabricate micron-
size BCAMM scaffolds using the artificial ECM source of BCM. 
The BCM could be effectively decellularized with preservation 
of its natural ECM structures, consequently providing a large 
surface area for cell adhesion and proliferation. The fabrication 
of the BCAMM may offer a viable source with potential 
advantages to replace the allogenic cartilage ECM in clinic 
applications.
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